• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    Waystar Holding Corp. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

    5/12/25 7:05:28 AM ET
    $WAY
    EDP Services
    Technology
    Get the next $WAY alert in real time by email
    false 0001990354 0001990354 2025-05-09 2025-05-09 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

     

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549 

     

    FORM 8-K

     

    CURRENT REPORT

    Pursuant to Section 13 or 15(d) of

    the Securities Exchange Act of 1934

     

    Date of Report (Date of earliest event reported): May 9, 2025

     

    Waystar Holding Corp.

    (Exact name of registrant as specified in its charter)

     

    Delaware 001-42125 84-2886542

    (State or other jurisdiction

    of incorporation)

    (Commission

    File Number)

    (IRS Employer

    Identification No.)

     

    1550 Digital Drive, #300

    Lehi, Utah 84043

    (Address of principal executive offices) (Zip Code)

     

    Registrant’s telephone number, including area code: (844) 492-9782

     

    Not applicable

    (Former name or former address, if changed since last report.)

     

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

     

    ¨  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
       
    ¨  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
       
    ¨  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
       
    ¨  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

     

    Securities registered pursuant to Section 12(b) of the Act:

     

    Title of
    each class
      Trading
    Symbol
      Name of each exchange
    on which registered
    Common Stock, par value $0.01 per share   WAY   The Nasdaq Stock Market LLC

     

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

     

    Emerging growth company x

     

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

     

     

     

     

     

     

    Item 5.02Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

     

    On May 9, 2025, the Compensation Committee of the Waystar Holding Corp. (the “Company”) Board of Directors (the “Board”) approved a grant of a target number of 396,197 performance stock units (“PSUs”) to Matt Hawkins, the Company’s Chief Executive Officer, under the Company’s 2024 Equity Incentive Plan (the “Plan”). The number of PSUs that will ultimately vest and be earned will be determined based on the Company’s total shareholder return (“TSR”) relative to a designated peer group consisting of all companies in the S&P SmallCap 600 Information Technology sector index over a four-year performance period beginning on April 1, 2025 and ending on April 1, 2029. Mr. Hawkins may earn up to 200% of the target number of PSUs granted, with no PSUs earned where relative TSR performance is less than the 30th percentile of the peer group, 50% of the target number of PSUs earned where relative TSR performance is at the 30th percentile of the peer group, 100% of the target number of PSUs earned where relative TSR performance is at the 55th percentile of the peer group, and 200% of the target number of PSUs earned if relative TSR performance equals or exceeds the 80th percentile of the peer group. To the extent relative TSR performance is between vesting levels, the portion of the PSUs that are earned will be determined using linear interpolation. Vesting of the PSUs is subject to Mr. Hawkins’ continuous employment with the Company through the end of the performance period. However, if, prior to the end of the performance period, Mr. Hawkins’ employment is terminated by the Company without “Cause” (as defined in the Plan), by Mr. Hawkins for “Good Reason” (as defined in his employment agreement with the Company) or as a result of his death or Disability (as defined in the Plan), he will remain eligible to earn a pro rata portion of the PSUs based on actual performance over the full performance period and prorated based on the portion of the performance period he was employed. 

     

    The PSUs are subject to the terms and conditions of the Plan and the award agreement governing the grant. A copy of the form of award agreement governing the PSUs is filed as Exhibit 10.1 to this Current Report on Form 8-K and is incorporated herein by reference.

     

    Item 8.01 Other Events.

     

    On April 29, 2025, the Company filed a definitive proxy statement on Schedule 14A for the solicitation of proxies in connection with the 2025 annual meeting of the Company’s stockholders (the “Annual Meeting”) to consider, among other proposals, approval of an amendment to the Company’s Amended and Restated Certificate of Incorporation (the “Certificate of Amendment”) to remove the existing limit on the maximum size of the Board. If approved by the Company’s stockholders at the Annual Meeting, the Company intends to promptly file the Certificate of Amendment with the Secretary of the State of Delaware to become effective at the time of filing. 

     

    On May 9, 2025, the Nominating and Corporate Governance Committee (the “Nominating Committee”) of the recommended that, upon the Certificate of Amendment becoming effective, the Board expand the size of the Board from ten directors to twelve directors and appoint Aashima Gupta to serve as a Class III director and Michael Roman to serve as a Class I director. The Nominating Committee further recommended that the Board determine that both Ms. Gupta and Mr. Roman be deemed to be independent under the applicable rules and regulations of the Nasdaq Global Select Market and the Corporate Governance Guidelines of the Company. In addition, the Nominating Committee recommended that Ms. Gupta be appointed to the Audit & Risk Committee of the Board and Mr. Roman be appointed to both the Audit and Risk Committee of the Board and the Nominating Committee. Each of Ms. Gupta and Mr. Roman’s appointments are contingent upon approval by the Board and the effectiveness of the Certificate of Amendment.

     

    Ms. Gupta, 54, joined Google Cloud in November 2016 and has served as Global Director, Healthcare Solutions, since November 2018. From January 2015 to November 2016, Ms. Gupta served as Vice President – Digital Transformation – Healthcare at Apigee, a Google Cloud Platform service, and from 2010 to January 2015, Ms. Gupta worked in technology development at Kaiser Permanente, most recently as its Executive Director of Digital Health. Ms. Gupta has served on the board of directors of Neogen, a publicly traded animal and food safety company, since 2022. In addition, she currently serves on the board of directors of Molnlycke Healthcare, a privately held medical technology company, and as a member of the board of advisors of HIMSS, a non-profit.

     

     

     

     

    Mr. Roman, 65, joined 3M Company, a diversified technology and manufacturing company, in 1988 where he served in a variety of roles, most recently as its chief executive officer from July 2018 until his retirement in May 2024. Since April 2021, Mr. Roman has served as a member of the board of directors of Abbott Laboratories. Mr. Roman served as chairman of the board of directors of 3M Company from May 2019 to May 2024 and then as its executive chairman from May 2024 to March 2025.

     

    There are no arrangements or understandings between Ms. Gupta or Mr. Roman and any other person pursuant to which they were recommended by the Nominating Committee to serve as members of the Board and there are no transactions in which either Ms. Gupta or Mr. Roman have a direct or indirect material interest that would be required to be disclosed under Item 404(a) of Regulation S-K promulgated under the Exchange Act of 1934, as amended, if they are appointed to the Board.

     

    Item 9.01 Financial Statements and Exhibits.

     

    (d) Exhibits.

     

    Exhibit No.   Description
    10.1   Form of Performance Stock Unit Agreement under the Waystar Holding Corp. 2024 Equity Incentive Plan
    104   Cover Page Interactive Data File (embedded within Inline XBRL document)

     

     

     

     

    Signatures

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed by the undersigned hereunto duly authorized.

     

    Date: May 12, 2025 Waystar Holding Corp.
         
      By: /s/ Gregory R. Packer
      Name: Gregory R. Packer
      Title: Chief Legal Officer

     

     

     

    Get the next $WAY alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $WAY

    DatePrice TargetRatingAnalyst
    3/14/2025$45.00Buy
    Truist
    2/11/2025$51.00Buy
    Jefferies
    11/22/2024$40.00Outperform → Strong Buy
    Raymond James
    7/2/2024$27.00Buy
    BofA Securities
    7/2/2024$24.00Overweight
    Barclays
    7/2/2024$27.00Buy
    Deutsche Bank
    7/2/2024$32.00Buy
    Goldman
    7/2/2024$24.00Overweight
    JP Morgan
    More analyst ratings

    $WAY
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Waystar Announces Proposed Public Offering of Common Stock

      LEHI, Utah and LOUISVILLE, Ky., May 13, 2025 /PRNewswire/ -- Waystar Holding Corp. (NASDAQ:WAY) ("Waystar"), a provider of leading healthcare payments software, today announced a proposed underwritten public offering of 12,500,000 shares of its common stock being offered by certain investment funds of EQT AB and Bain Capital, LP, and Canada Pension Plan Investment Board (CPP Investments), and their respective affiliates (collectively, the "Selling Stockholders"). Additionally, the Selling Stockholders intend to grant the underwriters a 30-day option to purchase up to 1,875,000 additional shares of common stock. Waystar is not selling any shares and will not receive any proceeds from the sale

      5/13/25 8:57:00 AM ET
      $WAY
      EDP Services
      Technology
    • Waystar Named Top Healthcare Payments Software Platform by MedTech Breakthrough

      Recognition underscores the differentiated value of Waystar's software platform in addressing nearly half a trillion dollars in administrative waste LEHI, Utah and LOUISVILLE, Ky., May 8, 2025 /PRNewswire/ -- Waystar (NASDAQ:WAY), a provider of leading healthcare payment software, today announced MedTech Breakthrough named it Best Overall Healthcare Payments Solutions Provider. This marks the fourth consecutive year that MedTech Breakthrough recognized Waystar, previously awarding the company the Healthcare Payments Innovation Award and Best New Technology Solution for Healthcare Payments.

      5/8/25 4:15:00 PM ET
      $WAY
      EDP Services
      Technology
    • Waystar to Present at Upcoming Investor Conferences

      LEHI, Utah and LOUISVILLE, Ky., April 30, 2025 /PRNewswire/ -- Waystar (NASDAQ:WAY), a provider of leading healthcare payment software, today announced that Chief Executive Officer Matt Hawkins and Chief Financial Officer Steve Oreskovich will speak at two upcoming investor conferences. Oreskovich will present at the Bank of America Securities Healthcare Conference on Wednesday, May 14, 2025, at 8:40 a.m. PT. Hawkins will present at the William Blair 45th Annual Growth Stock Conference on Tuesday, June 3, 2025, at 12 p.m. CT. Both presentations will stream live on Waystar's In

      4/30/25 4:15:00 PM ET
      $WAY
      EDP Services
      Technology

    $WAY
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Chief Technology Officer Schremser Christopher L. exercised 8,623 shares at a strike of $4.14 and sold $346,352 worth of shares (8,623 units at $40.17) (SEC Form 4)

      4 - Waystar Holding Corp. (0001990354) (Issuer)

      5/12/25 4:52:18 PM ET
      $WAY
      EDP Services
      Technology
    • Chief Executive Officer Hawkins Matthew J. was granted 264,131 shares, increasing direct ownership by 53% to 764,131 units (SEC Form 4)

      4 - Waystar Holding Corp. (0001990354) (Issuer)

      5/12/25 8:37:21 AM ET
      $WAY
      EDP Services
      Technology
    • Chief Technology Officer Schremser Christopher L. exercised 8,623 shares at a strike of $4.14 and sold $313,546 worth of shares (8,623 units at $36.36) (SEC Form 4)

      4 - Waystar Holding Corp. (0001990354) (Issuer)

      4/14/25 4:31:13 PM ET
      $WAY
      EDP Services
      Technology

    $WAY
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G filed by Waystar Holding Corp.

      SC 13G - Waystar Holding Corp. (0001990354) (Subject)

      11/14/24 5:30:28 PM ET
      $WAY
      EDP Services
      Technology
    • SEC Form SC 13G filed by Waystar Holding Corp.

      SC 13G - Waystar Holding Corp. (0001990354) (Subject)

      11/14/24 6:00:14 AM ET
      $WAY
      EDP Services
      Technology
    • SEC Form SC 13G filed by Waystar Holding Corp.

      SC 13G - Waystar Holding Corp. (0001990354) (Subject)

      11/8/24 4:30:50 PM ET
      $WAY
      EDP Services
      Technology

    $WAY
    Financials

    Live finance-specific insights

    See more

    $WAY
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Waystar Reports First Quarter 2025 Results

      Q1 revenue growth of 14% year-over-year Q1 net income of $29.3 million and non-GAAP net income of $58.7 million Q1 net income margin of 11%; adjusted EBITDA margin of 42% Raising revenue and adjusted EBITDA guidance for 2025 LEHI, Utah and LOUISVILLE, Ky., April 30, 2025 /PRNewswire/ -- Waystar Holding Corp. (NASDAQ:WAY), a provider of leading healthcare payment software, today reported results for the first quarter ended March 31, 2025. "Waystar sustained strong momentum in the first quarter of 2025, delivering net income margins exceeding 10%, adjusted EBITDA margins excee

      4/30/25 4:05:00 PM ET
      $WAY
      EDP Services
      Technology
    • Waystar to Announce First Quarter 2025 Financial Results on April 30, 2025

      LEHI, Utah and LOUISVILLE, Ky., April 7, 2025 /PRNewswire/ -- Waystar Holding Corp. (NASDAQ:WAY), a provider of leading healthcare payment software, announced today that it will report financial results for the first quarter ended March 31, 2025, after market close on Wednesday, April 30, 2025. The company will discuss its financial results on a conference call at 4:30 p.m. Eastern Time that same day. A live audio webcast of the conference call will be available on Waystar's investor relations website at https://investors.waystar.com/news-events/events. The webcast will be arc

      4/7/25 4:30:00 PM ET
      $WAY
      EDP Services
      Technology
    • Waystar Reports Fourth Quarter and Fiscal Year 2024 Results

      Fiscal year 2024 revenue of $944M, up 19% YoY Q4 revenue growth of 18% year-over-year Q4 net income of $19.1 million and non-GAAP net income of $52.1 million Fiscal year 2024 net loss $19.1 million, 62.7% improvement YoY Fiscal year 2024 adjusted EBITDA of $383M, up 15% YoY Q4 net income margin of 8%; adjusted EBITDA margin of 41% LEHI, Utah and LOUISVILLE, Ky., Feb. 18, 2025 /PRNewswire/ -- Waystar Holding Corp. (NASDAQ:WAY), a provider of leading healthcare payment software, today reported results for the fourth quarter and full year ended December 31, 2024. "We are please

      2/18/25 7:00:00 AM ET
      $WAY
      EDP Services
      Technology
    • Truist initiated coverage on Waystar Holding Corp. with a new price target

      Truist initiated coverage of Waystar Holding Corp. with a rating of Buy and set a new price target of $45.00

      3/14/25 7:43:51 AM ET
      $WAY
      EDP Services
      Technology
    • Jefferies initiated coverage on Waystar Holding Corp. with a new price target

      Jefferies initiated coverage of Waystar Holding Corp. with a rating of Buy and set a new price target of $51.00

      2/11/25 7:16:09 AM ET
      $WAY
      EDP Services
      Technology
    • Waystar Holding Corp. upgraded by Raymond James with a new price target

      Raymond James upgraded Waystar Holding Corp. from Outperform to Strong Buy and set a new price target of $40.00

      11/22/24 8:07:26 AM ET
      $WAY
      EDP Services
      Technology

    $WAY
    Leadership Updates

    Live Leadership Updates

    See more
    • Ardent Health Appoints Robert DeMichiei to Board of Directors

      Ardent Health (NYSE:ARDT), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced the appointment of Robert A. DeMichiei to its board of directors. A seasoned leader with over 30 years of experience in financial strategy, healthcare operations, and board governance, Mr. DeMichiei served as executive vice president and chief financial officer at the University of Pittsburgh Medical Center (UPMC) from 2004 to 2020. During his tenure, he played a pivotal role in driving UPMC's financial growth and led numerous strategic initiatives, including mergers and acquisitions, supply chain management, and revenue cycle improvements. Prior to joining U

      4/3/25 5:27:00 PM ET
      $AP
      $ARDT
      $HCAT
      $WAY
      Fluid Controls
      Industrials
      Hospital/Nursing Management
      Health Care

    $WAY
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Chairperson Driscoll John Patrick was granted 8,695 shares and bought $129,000 worth of shares (6,000 units at $21.50), increasing direct ownership by 21% to 85,623 units (SEC Form 4)

      4 - Waystar Holding Corp. (0001990354) (Issuer)

      6/12/24 4:32:09 PM ET
      $WAY
      EDP Services
      Technology

    $WAY
    SEC Filings

    See more
    • SEC Form S-1 filed by Waystar Holding Corp.

      S-1 - Waystar Holding Corp. (0001990354) (Filer)

      5/13/25 8:50:31 AM ET
      $WAY
      EDP Services
      Technology
    • SEC Form DEFA14A filed by Waystar Holding Corp.

      DEFA14A - Waystar Holding Corp. (0001990354) (Filer)

      5/12/25 7:05:52 AM ET
      $WAY
      EDP Services
      Technology
    • Waystar Holding Corp. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

      8-K - Waystar Holding Corp. (0001990354) (Filer)

      5/12/25 7:05:28 AM ET
      $WAY
      EDP Services
      Technology